Engineered solely for preclinical investigations, each batch of Dihexa undergoes a comprehensive quality assessment and includes complete documentation, including a Certificate of Analysis (COA), purity data, and structural verification
Tirzepatide (brand names Mounjaro and Zepbound): A dual-action medication that activates both GLP-1 and GIP receptors, tirzepatide has demonstrated even more impressive weight loss outcomes, with studies showing average weight loss of 15.0% to 20.9% of body weight
C.OjhaR
Oltre che nei casi di comorbilit con patologie mediche come accade in presenza di disturbi alimentari e obesit, la comunit scientifica rileva in tempi recenti la possibilit delluso di tali farmaci per trattare e ridurre gli episodi di abbuffate (anche se non sono presenti effetti a lungo termine) che caratterizzano il binge eating e la bulimia
Abdulmalik, S., Gallo, J., Nip, J., Katebifar, S., Arul, M., Lebaschi, A., et al
CJC-1295 Without DAC (Mod-GRF 1-29) pharmacological characterisation: Studies characterising the tetrasubstituted Mod-GRF 1-29 sequence established that the four amino acid substitutions produce a DPP-IV-resistant, endopeptidase-stable GHRH analogue with approximately 30-minute plasma half-life substantially extended versus native GHRH(1-29) without the albumin-binding continuous release profile of the DAC variant